APG Asset Management US’s AbbVie ABBV Stock Holding History

APG Asset Management US’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-37,008	Closed	-$9.04M	–	59
2025 Q3	$9.04M	Buy	37,008 +232	+0.6%	+$47.2K	0.07%	60
2025 Q2	$6.99M	Buy	36,776 +274	+0.8%	+$50.9K	0.05%	64
2025 Q1	$7.53M	Hold	36,502	–	–	0.06%	63
2024 Q4	$6.49M	Sell	36,502 -4,627	-11%	-$851K	0.05%	64
2024 Q3	$8.1M	Sell	41,129 -517,198	-93%	-$96.5M	0.05%	57
2024 Q2	$95.1M	Buy	558,327 +53,265	+11%	+$8.82M	0.54%	34
2024 Q1	$91.3M	Buy	505,062 +159,037	+46%	+$27.4M	0.53%	35
2023 Q4	$53.6M	Buy	+346,025	New	+$50.4M	0.33%	35

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

APG Asset Management US's ABBV Position: Q4 2025 in Review

APG Asset Management US sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 37,008 shares — an estimated $9.04M sold.

APG Asset Management US first reported a position in ABBV in Q4 2023 and held it in 8 quarters. The position peaked at $95.1M in Q2 2024. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

APG Asset Management US reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
APG Asset Management US sold 37,008 AbbVie shares in Q4 2025, an estimated $9.04M.
APG Asset Management US first reported a position in AbbVie in Q4 2023 and held it in 8 quarters.
APG Asset Management US's AbbVie position peaked at $95.1M in Q2 2024.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.